Valink Therapeutics
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.
- Website
- valinktx.com
- City
- Boston
- Country
- United States
- YC batch
- Winter 2021
- Team
- 15 people
- Stage
- Early stage
- AI-native
- No
See it on the Boston mapSource Spot something wrong?
Compiled from public sources with help from automated tools, including AI, so details can be out of date. How we build profiles.
More Health & bio in Boston
WHOOP$10.1bn
Wearable technology. Valued at $10.1bn (March 2026).
Ginkgo BioworksHiring
Our mission is to make biology easier to engineer.
Modern HealthHiring
A mental health benefits platform for employers.
TetraScience
The only R&D data cloud for life sciences
OpenBiome
A nonprofit stool bank enabling access to fecal transplants.
SiPhox HealthHiring
At-Home health monitoring with silicon photonic chips for data centers
Claim this profile
Free and instant: prove you run valinktx.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Valink Therapeutics across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Valink Therapeutics's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
